The director of mental health and addiction services shall annually conduct an on-site review of each community mental health services provider and community addiction services provider that is an opioid treatment program described in division (D)(2)(b) of section 4729.291 of the Revised Code. The review may include an inspection of pharmacy records as described in section 3719.13 of the Revised Code and a n inspection of patient treatment records. If the director has reason to believe that a violation of local, state, or federal drug law, including any provision of Chapter 2925., 3715., 3719., or 4729. of the Revised Code, has occurred, the director s hall report that information to the state board of pharmacy.
The director may adopt rules in accordance with Chapter 119. of the Revised Code to implement this section.
Added by 131st General Assembly File No. TBD, HB 4, ยง1, eff. 7/16/2015.
Section: Previous 5119.361 5119.362 5119.363 5119.364 5119.365 5119.37 5119.371 5119.372 5119.38 5119.39 5119.391 5119.392 5119.40 5119.41 5119.411 NextLast modified: October 10, 2016